Literature DB >> 8652241

Safe selection criteria for breast conservation without radical excision in primary operable invasive breast cancer.

D M Sibbering1, M H Galea, D A Morgan, C W Elston, I O Ellis, J F Robertson, R W Blamey.   

Abstract

In a previous series from this unit of 263 women with primary operable breast cancer treated by macroscopic lumpectomy and breast irradiation, local recurrence was high. An audit at a median follow up of 36 months showed 56 (21%) ipsilateral breast recurrences. Eighteen of these recurrences were aggressive and uncontrolled. Multivariate analysis shows patient age, lymphovascular invasion, tumour size and nodal status to be predictive of local recurrence (Locker AP, et al., Br J Surgery 1989, 76, 890-894). New selection criteria for breast conservation were defined based on these data and also on securing an adequate clear margin of excision. In a subsequent prospective series of 275 women fulfilling these criteria, 6 women (2.2%) developed ipsilateral breast recurrence at the same median follow up of 36 months. In none was this uncontrolled and aggressive. Breast conservation, without radical excision, is safe as long as the selection criteria described are followed.

Entities:  

Mesh:

Year:  1995        PMID: 8652241     DOI: 10.1016/0959-8049(95)00455-6

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  3 in total

1.  Breast conserving surgery with preservation of the nipple-areola complex as a feasible and safe approach in male breast cancer: a case report.

Authors:  Sophocles Lanitis; George Filippakis; Ragheed Al Mufti; Dimitri J Hadjiminas
Journal:  J Med Case Rep       Date:  2008-04-28

2.  The importance of margins status after breast conservative surgery and radiotherapy in node positive patients: a follow-up of 10-15 years.

Authors:  Isabella Besana-Ciani; Michael J Greenall
Journal:  Int Semin Surg Oncol       Date:  2008-05-22

3.  Expansion of Masood's cytologic index for breast carcinoma and its validity.

Authors:  Ts Rekha; Nm Nandini; Murali Dhar
Journal:  J Cytol       Date:  2013-10       Impact factor: 1.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.